Ellis Investment Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,507
| Closed | -$82K | – | 243 |
|
|
2022
Q3 | $82K | Buy |
1,507
+11
| +0.7% | +$599 | 0.02% | 319 |
|
|
2022
Q2 | $98K | Sell |
1,496
-43
| -3% | -$2.82K | 0.03% | 306 |
|
|
2022
Q1 | $102K | Sell |
1,539
-53
| -3% | -$3.51K | 0.02% | 313 |
|
|
2021
Q4 | $92K | Buy |
1,592
+916
| +136% | +$52.9K | 0.02% | 333 |
|
|
2021
Q3 | $40K | Buy |
676
+4
| +0.6% | +$237 | 0.01% | 424 |
|
|
2021
Q2 | $40K | Sell |
672
-1
| -0.1% | -$60 | 0.01% | 427 |
|
|
2021
Q1 | $33K | Sell |
673
-298
| -31% | -$14.6K | 0.01% | 440 |
|
|
2020
Q4 | $49K | Hold |
971
| – | – | 0.01% | 376 |
|
|
2020
Q3 | $53K | Buy |
971
+7
| +0.7% | +$382 | 0.02% | 357 |
|
|
2020
Q2 | $51K | Buy |
964
+380
| +65% | +$20.1K | 0.02% | 356 |
|
|
2020
Q1 | $25K | Buy |
584
+93
| +19% | +$3.98K | 0.01% | 376 |
|
|
2019
Q4 | $24K | Hold |
491
| – | – | 0.01% | 421 |
|
|
2019
Q3 | $21K | Buy |
491
+5
| +1% | +$214 | 0.01% | 436 |
|
|
2019
Q2 | $20K | Buy |
+486
| New | +$20K | 0.01% | 440 |
|